Fig A1.
Patient receiving abiraterone exhibiting signs of metabolic bone flare on sodium fluoride (NaF) positron emission tomography/computed tomography from (A) baseline to (B) week 6 (increasing NaF uptake) before subsiding at (C) week 12.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.